U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
86413
Substance Class Mixture
Created
by admin
on Fri Dec 15 16:31:34 UTC 2023
Edited
by admin
on Fri Dec 15 16:31:34 UTC 2023
Record UNII
5ASJ6HUZ7D
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DOXEPIN
HSDB   INN   MI   VANDF   WHO-DD  
INN  
Official Name English
DOXEPIN [VANDF]
Common Name English
DOXEPINE
Common Name English
Doxepin [WHO-DD]
Common Name English
DOXEPIN IS A CIS-TRANS (APPROXIMATELY 1:5) MIXTURE
Common Name English
DOXEPIN [MI]
Common Name English
3-DIBENZO(B,E)OXEPIN-11(6H)-YLIDENE-N,N-DIMETHYLPROPAN-1-AMINE
Common Name English
1-PROPANAMINE, 3-DIBENZ(B,E)OXEPIN-11(6H)-YLIDENE-N,N-DIMETHYL-
Common Name English
DOXEPIN [HSDB]
Common Name English
doxepin [INN]
Common Name English
Classification Tree Code System Code
WHO-VATC QN06AA12
Created by admin on Fri Dec 15 16:31:34 UTC 2023 , Edited by admin on Fri Dec 15 16:31:34 UTC 2023
WHO-ATC N06AA12
Created by admin on Fri Dec 15 16:31:34 UTC 2023 , Edited by admin on Fri Dec 15 16:31:34 UTC 2023
LIVERTOX NBK548035
Created by admin on Fri Dec 15 16:31:34 UTC 2023 , Edited by admin on Fri Dec 15 16:31:34 UTC 2023
WHO-ATC D04AX01
Created by admin on Fri Dec 15 16:31:34 UTC 2023 , Edited by admin on Fri Dec 15 16:31:34 UTC 2023
NCI_THESAURUS C94727
Created by admin on Fri Dec 15 16:31:34 UTC 2023 , Edited by admin on Fri Dec 15 16:31:34 UTC 2023
NDF-RT N0000175752
Created by admin on Fri Dec 15 16:31:34 UTC 2023 , Edited by admin on Fri Dec 15 16:31:34 UTC 2023
Code System Code Type Description
RXCUI
3638
Created by admin on Fri Dec 15 16:31:34 UTC 2023 , Edited by admin on Fri Dec 15 16:31:34 UTC 2023
PRIMARY RxNorm
MERCK INDEX
m4753
Created by admin on Fri Dec 15 16:31:34 UTC 2023 , Edited by admin on Fri Dec 15 16:31:34 UTC 2023
PRIMARY Merck Index
EVMPD
SUB06387MIG
Created by admin on Fri Dec 15 16:31:34 UTC 2023 , Edited by admin on Fri Dec 15 16:31:34 UTC 2023
PRIMARY
WIKIPEDIA
DOXEPIN
Created by admin on Fri Dec 15 16:31:34 UTC 2023 , Edited by admin on Fri Dec 15 16:31:34 UTC 2023
PRIMARY
DAILYMED
5ASJ6HUZ7D
Created by admin on Fri Dec 15 16:31:34 UTC 2023 , Edited by admin on Fri Dec 15 16:31:34 UTC 2023
PRIMARY
DRUG BANK
DB01142
Created by admin on Fri Dec 15 16:31:34 UTC 2023 , Edited by admin on Fri Dec 15 16:31:34 UTC 2023
PRIMARY
INN
1855
Created by admin on Fri Dec 15 16:31:34 UTC 2023 , Edited by admin on Fri Dec 15 16:31:34 UTC 2023
PRIMARY
CHEBI
4710
Created by admin on Fri Dec 15 16:31:34 UTC 2023 , Edited by admin on Fri Dec 15 16:31:34 UTC 2023
PRIMARY
IUPHAR
1225
Created by admin on Fri Dec 15 16:31:34 UTC 2023 , Edited by admin on Fri Dec 15 16:31:34 UTC 2023
PRIMARY
CAS
1668-19-5
Created by admin on Fri Dec 15 16:31:34 UTC 2023 , Edited by admin on Fri Dec 15 16:31:34 UTC 2023
PRIMARY
DRUG CENTRAL
956
Created by admin on Fri Dec 15 16:31:34 UTC 2023 , Edited by admin on Fri Dec 15 16:31:34 UTC 2023
PRIMARY
MESH
D004316
Created by admin on Fri Dec 15 16:31:34 UTC 2023 , Edited by admin on Fri Dec 15 16:31:34 UTC 2023
PRIMARY
NCI_THESAURUS
C65475
Created by admin on Fri Dec 15 16:31:34 UTC 2023 , Edited by admin on Fri Dec 15 16:31:34 UTC 2023
PRIMARY
ChEMBL
CHEMBL1628227
Created by admin on Fri Dec 15 16:31:34 UTC 2023 , Edited by admin on Fri Dec 15 16:31:34 UTC 2023
PRIMARY
PUBCHEM
3158
Created by admin on Fri Dec 15 16:31:34 UTC 2023 , Edited by admin on Fri Dec 15 16:31:34 UTC 2023
PRIMARY
SMS_ID
100000080813
Created by admin on Fri Dec 15 16:31:34 UTC 2023 , Edited by admin on Fri Dec 15 16:31:34 UTC 2023
PRIMARY
FDA UNII
5ASJ6HUZ7D
Created by admin on Fri Dec 15 16:31:34 UTC 2023 , Edited by admin on Fri Dec 15 16:31:34 UTC 2023
PRIMARY
LACTMED
Doxepin
Created by admin on Fri Dec 15 16:31:34 UTC 2023 , Edited by admin on Fri Dec 15 16:31:34 UTC 2023
PRIMARY
EPA CompTox
DTXSID7022966
Created by admin on Fri Dec 15 16:31:34 UTC 2023 , Edited by admin on Fri Dec 15 16:31:34 UTC 2023
PRIMARY
HSDB
3069
Created by admin on Fri Dec 15 16:31:34 UTC 2023 , Edited by admin on Fri Dec 15 16:31:34 UTC 2023
PRIMARY
All of the following components must be present:
Structure of DOXEPIN, (E)-
Structure of CIDOXEPIN
Related Record Type Details
HISTAMINE H2 RECEPTOR
TARGET -> INHIBITOR
HISTAMINE H1 RECEPTOR
TARGET -> INHIBITOR
PLASMA PROTEIN FRACTION (HUMAN)
BINDER->LIGAND
MUSCARINIC ACETYLCHOLINE RECEPTOR M2
TARGET -> INHIBITOR
5-HYDROXYTRYPTAMINE RECEPTOR 2B
TARGET -> INHIBITOR
OCT-2
TRANSPORTER -> INHIBITOR
MUSCARINIC ACETYLCHOLINE RECEPTOR M1
TARGET -> INHIBITOR
5-HYDROXYTRYPTAMINE RECEPTOR 2C
TARGET -> INHIBITOR
MUSCARINIC ACETYLCHOLINE RECEPTOR M4
TARGET -> INHIBITOR
5-HYDROXYTRYPTAMINE RECEPTOR 2A
TARGET -> INHIBITOR
MUSCARINIC ACETYLCHOLINE RECEPTOR M3
TARGET -> INHIBITOR
MUSCARINIC ACETYLCHOLINE RECEPTOR M5
TARGET -> INHIBITOR
Related Record Type Details
DESMETHYLDOXEPIN
METABOLITE ACTIVE -> PARENT
Related Record Type Details
DOXEPIN
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC
Volume of Distribution PHARMACOKINETIC
Definition References
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966